Current Prevalence of Substance Use Disorders and Its Dynamics in the Republic of Crimea: A Retrospective Study

Introduction: The study of the prevalence of narcological disorders is an integral part of the monitoring of the drug situation allowing identification of the main trends in the situation with the use of narcotic drugs.
Objective: To analyze the level and structure of non-medical use of prescription drugs among the population of the Republic of Crimea and to assess their dynamics in 2020–2021.
Materials and methods: The subject of the study was quantitative indicators characterizing the spread of drug use disorders in the Republic of Crimea. The information base of the study included data and materials of the Federal State Statistics Service and the Ministry of Health of the Republic of Crimea. We processed data of the statistical reporting documentation for 2020–2021, Forms No. 37, Information on patients with alcoholism, drug addiction, substance abuse, and No. 11, Incidence of substance use disorders. Incidence and prevalence rates were estimated per 100 thousand population. The data were analyzed in Microsoft Excel. Results: We established an increase in the incidence of substance use disorders in the Republic of Crimea in 2020–2021 from 38.3 to 42.9 per 100 thousand population (by 12.01 % in the year 2021 compared to 2020) and an increase in the overall incidence of drug addiction and abuse from 566.5 to 578.3 per 100 thousand population (2.08 %). We noted a slight decrease in opium addiction, transition to new synthetic drugs, and an increase in the proportion of a combined use of narcotic drugs. Males aged 20 to 59 years predominate among drug users.
Conclusions: Our findings show a consistently high prevalence of non-medical use of prescription drugs among the population in the Republic of Crimea, an increase in the incidence and prevalence of drug addiction and in the number of doctor’s visits among drug abusers, and a growth of drug overdose deaths.

1. Pozdnyakova ME, Bruno VV. Comparative sociological analysis of changes in the situation with drug consumption in Russia over 30 years: 1990–2020. Problems of Narcology. 2021;5(200):15–51. (In Russ). doi: 10.47877/0234-0623_2021_05_15

2. Klimenko TV, Kozlov AA. Global preventive space as a mechanism for the prevention of non-medical consumption of psychoactive substances and the formation of a healthy lifestyle. Problems of Narcology. 2021; 3(98);7-18. (In Russ). doi: 10.47877/0234-0623_2021_03_7

3. Kirzhanova VV. The drug situation in the Russian Federation in the light of the implementation of the state anti-drug policy. Problems of Narcology. 2021;10 (205):5–37. (In Russ). doi: 10.47877/0234-0623_2021_10_5

4. Semenova NV, Vishnyakov NI, Kurkova ES, Skripov VS. Esina KM, Tominina EV, Kulakov DD. The incidence of drug addiction and alcoholism in the Russian Federation in the first two decades of the XXI century. Dynamics and main trends. Social aspects of public health. 2022;68(4);1-24. (In Russ). doi: 10.21045/2071-5021-2022-68-4-15

5. Bryun EA, Melikhov MG, Koshkina EA, Kirzhanova VV, Smirnovskaya MS., Negai NA, Baipeisov DM, Muzafarov RKh, Shevtsova YuB., Skryabin VYu. On the drug situation in the member states of the Collective Security Treaty Organization. Narcology. 2021; 20(1):14–25. (In Russ). doi: 10.25557/1682-8313.2021.01.14-25

6. Jenkins R. Global mental health and sustainable development 2018. BJPsych Int. 2019:16 (2):34–37. doi: 10.1192/bji.2019.5

7. Klimenko TV, Korchagina GA, Fadeeva EV, Vyshinsky KV. Design and methodology for studying the impact of the COVID-19 pandemic on the model of psychoactive substance consumption. Problems of Narcology. 2021; 2(197): 74–99. (In Russ) doi: 10.47877/0234-0623_2021_02_74

8. Rozhanets VV, Fadeeva EV, Klimenko TV. Problems of addiction in the era of COVID-19-current data and trend analysis, 2020. Problems of Narcology. 2021;1 (196):5–19. (In Russ) doi: 10.47877/0234-0623_2021_01_5

9. Rozhanets VV, Klimenko TV, Eganov AA, Eroshchenko NN, Kiryushin AN, Kharlamova NA, Senshinov IV, Pryadka AA, Nosyrev AE. Evaluation of the impact of the second wave of the COVID-19 pandemic on the consumption of alcohol, tobacco and morphine in a limited population using wastewater analysis. Problems of Narcology. 2022; 1 (208):39–56. (In Russ). doi: 10.47877/0234-0623_2022_1_39

10. Kislitsyna OA. Long-term negative consequences of the COVID-19 pandemic for public health. Social aspects of public health. 2021;67(4):2. (In Russ). doi: 10.21045/2071-5021-2021-67-4-2

11. Kirzhanova VV, Vyshinsky KV, Fadeeva EV, Klimenko TV, Korchagina GA, Kholdin VN. The study of factors associated with changes in the frequency and volume of alcohol consumption in the initial period of the COVID-19 pandemic among persons with risky and harmful consumption of psychoactive substances. Problems of Narcology. 2022. No. 2-3 (209). pp. 62–94. (In Russ). doi: 10.47877/0234-0623_2022_2-3_62

12. Chatterjee SS, Barikar CM. Mukherjee A. Impact of COVID-19 pandemic on preexisting mental health problems. Asian Journal of Psychiatry. 2020;51: 102071. doi:10.1016/j.ajp.2020.102071.

13. Rybakova KV, Grigoriev AV, Semenova NV, Skurat EP, Zubova EYu, Neznanov NG, Krupitsky EM. Features of the provision of drug treatment during the COVID-19 pandemic. Review of Psychiatry and Medical Psychology named after V.M. Bekhterev. 2021; 55(2):45–51. (In Russ). doi: 10.31363/2313-7053-2021-55-2-45-51

14. Gornov VA. The impact of the pandemic of a new coronavirus infection on the drug situation (regional cross-section on the example of the Ryazan region. Sociosphere. 2021;4:96-100. (In Russ.).

15. Dumas TM, Ellis W, Litt DM. What does the use of psychoactive substances by adolescents during the COVID-19 pandemic look like? Study of changes in frequency, social contexts, and pandemic-related predictors. J Adolescent health. 2020;67(3):354-361. doi: 10.1016/j.jadohealth.2020.06.018

16. EMCDDA Trendspotter brieng: The impact of COVID-19 on drug use patterns and drug-related harm in Europe. EMCDDA, Lisbon, June 2020. doi: 10.2810/830360.

17. The World Drug Report 2021. Vienna: United Nations Office on Drugs and Crime (UNODC), 2021.

18. Kirzhanova VV, Grigorova NI, Bobkov EN, Kirzhanov VN, Sidoryuk OV. The activities of the Narcological Service of the Russian Federation in 2019-2020: An analytical review. Moscow:FSBI "NMITS PN named after V.P. Serbsky" of the Ministry of Health of Russia; 2021. (In Russ).

19. Kirzhanova VV, Grigorova NI, Bobkov EN, Kirzhanov VN., Sidoryuk OV. The state and activities of the narcological service in the Russian Federation in 2021: An analytical review. Moscow:FSBI "NMITS PN named after V.P. Serbsky" of the Ministry of Health of Russia; 2022. (In Russ).

20. Sharonov AN., Prykin AV. Current issues of drug dependency treatment delivery in the Russian Federation. Vestnik Roszdravnadzora. 2020;2:75-79. (In Russ). doi: 10.35576/2070-7940-2020-2-75-79

21.